Diligence memo · auto-generated · as of July 2, 2026
Eleusis Benefit Corporation, PBC
Eleusis Benefit Corporation, PBC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Eleusis Benefit Corporation, PBC operates in Pharmaceuticals, based in NEW YORK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Eleusis Benefit Corporation, PBC has raised $1.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $976K on 2016-05-20.
Most recent recorded round closed around 2016-05-20.
Valuation (modeled)modeled
Provath models Eleusis Benefit Corporation, PBC at approximately $46M (range $547K–$524M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.44× the median modeled value of Pre-Seed Pharmaceuticals companies in 2016–2018 (56 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 10.1 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 26% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 41% of those peers.
Closest niche peers: Essentia Pharma Socal, Llc, Essentia Pharma Florida, Llc, Novellus LLC, Blake Insomnia Therapeutics, Inc., T.A.Z. Corp.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.